Table 1.
Overview of individual study attributes.
| Article | Country | Journal | Year | Study Type | Intervention Used | Participants | Fundoscopic Exclusion | Rate of Macular Pathology Detection | Type of Pathology detected |
|---|---|---|---|---|---|---|---|---|---|
| Sudhalkar et al. [8] | India | AJO | 2019 | Case series | SD-OCT | 1444 eyes of 1444 patients |
- Fundoscopy done - Eyes appearing abnormal on fundoscopic exam were excluded |
SD-OCT: 133 eyes (9.21%) |
SD-OCT: Interface abnormalities = 94 Macular degeneration = 26 Foveal attenuation = 8 Macular oedema = 5 Miscellaneous = 3 |
| Tognetto et al. [17] | Italy | Scientific Reports | 2019 | Cross-sectional study | SD-OCT & SS-OCT (Biometer) | 1089 eyes of 732 patients | - Fundoscopy not done |
SD-OCT 449 eyes (41.2%) SS-OCT 364 eyes (33.4%) |
SD-OCT Full-thickness macular holes = 16 (1.5%), Interface abnormalities = 33 (3%) Macular degeneration = 210 (19.4%) Macular oedema = 169 (15.6%) |
| Pinto et al. [15] | Brazil | JCRS | 2019 | Case series | SD-OCT | 952 eyes of 614 patients |
- Fundoscopy done - Eyes appearing abnormal on fundoscopic exam were excluded |
SD-OCT: 47 eyes (4.9%) |
SD-OCT Interface abnormalities = 35 (3.7%) Macular degeneration = 7 (0.4%) Macular oedema = 4 (0.4%) FTMH = 1 (0.1%) |
| Abdelmassih et al. [14] | France | JCRS | 2018 | Case series | SD-OCT | 401 eyes of 245 patients |
- Fundoscopy done - Eyes with abnormal fundoscopy findings were included in OCT intervention group |
SD-OCT: 107 (26.7%) Fundoscopy: 37 (9.23%) |
SD-OCT Macular degeneration = 66 (61.7%) Interface abnormalities = 32 (30%) Miscellaneous = 5 (4.6%) Macular oedema = 4 (3.7%) |
| Kowallic et al. [11] | Germany | PLoS One | 2018 | Case series | SD-OCT | 162 eyes of 123 patients |
- Fundoscopy done - Eyes appearing abnormal on fundoscopic exam were excluded |
SD-OCT: 20 eyes (12.35%) |
Interface abnormalities = 10 (6.17%) Macular degeneration = 6 (3.71%) Miscellaneous = 4 (2.47%) |
| Huang et al. [9] | China | Scientific Reports | 2018 | Case series | SD-OCT | 992 eyes of 992 patients |
- Fundoscopy done - Eyes appearing abnormal on fundoscopic exam were excluded |
SD-OCT: 294 eyes (25%) |
SD-OCT: Interface abnormalities = 135 Macular degeneration = 160 Miscellaneous = 46 Macular oedema = 22 FTMH = 14 |
| Zafar et al. [16] | Pakistan | JCRS | 2017 | Case series | SS-OCT | 155 eyes of 155 patients |
- Fundoscopy done - Eyes appearing abnormal on fundoscopic exam were excluded |
SS-OCT: 17 eyes (10.9%) |
SS-OCT: Macular degeneration = 5 Interface abnormality = 6 Macular oedema = 2 |
| Hirnschall et al. [10] | Austria | JCRS | 2016 | Case series | SD-OCT & SS-OCT (Biometer) | 125 eyes of 125 patients | - Fundoscopy not done |
SD-OCT: 65 eyes (54.2%) SS-OCT: 38 eyes (28%) |
SD-OCT: Interface abnormalities = 30 (25%) FTMH = 5 (4.2%) Macular degeneration = 16 (13.4%) Macular oedema = 16 (13.3%) |
| Klein et al. [13] | USA | JCRS | 2016 | Case series | SD-OCT | 265 eyes of 149 patients |
- Fundoscopy done - Eyes appearing abnormal on fundoscopic exam were excluded |
SD-OCT: 35 eyes (13.2%) |
SD-OCT: Macular degeneration = 20 (7.55%) Interface abnormalities = 11 (4.15%) Macular oedema = 3 (1.13%) |
| Neto et al. [12] | Germany | Arq Bras Oftalmol | 2015 | Case series | SD-OCT | 98 eyes of 98 patients |
- Fundoscopy done - Eyes with abnormal fundoscopy findings were included in OCT intervention group |
SD-OCT: 21 eyes (21.4%) Fundoscopy: 11 eyes (11.2%) |
Fundoscopy: Macular degeneration = 11 SD-OCT: Macular degeneration = 7 Interface abnormalities = 3 |
| Creese et al. [5] | Austria | Clinical and Experimental Ophthalmology | 2011 | Case series | SD-OCT | 218 eyes of 149 patients |
- Fundoscopy done - Eyes appearing abnormal on fundoscopic exam were excluded |
SD-OCT: 10 eyes (4.6%) |
SD-OCT Interface abnormalities = 5 Macular degeneration = 3 FTMH = 1 Macular oedema = 1 |